We are live on ! Find out more
NIP

Nicholas Investment Partners Portfolio holdings

AUM $1.78B
1-Year Est. Return 114.03%
This Fund
S&P 500
This Quarter Est. Return
+34.81%
1 Year Est. Return
+114.03%
3 Year Est. Return
+397.19%
5 Year Est. Return
+640.97%
10 Year Est. Return
+4,729.95%
AUM
$1.78B
AUM Growth
+$390M
Cap. Flow
-$130M
Cap. Flow %
-7.34%
Top 10 Hldgs %
17.89%
Holding
245
New
38
Increased
75
Reduced
41
Closed
41

Sector Composition

Rank Sector Weight
1 Technology 21.01%
2 Industrials 19.29%
3 Healthcare 15.59%
4 Miscellaneous 12.21%
5 Consumer Discretionary 12.2%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BWXT icon
1
BWX Technologies
BWXT
$14.4B
$53M 2.99%
272,395
+10,528
+4% +$2.19M
RVMD icon
2
Revolution Medicines
RVMD
$45B
$45.8M 2.58%
244,594
-16,572
-6% -$2.42M
CALY
3
Callaway Golf Company
CALY
$2.84B
$36.7M 2.07%
1,954,378
+828,394
+74% +$13M
MOD icon
4
Modine Manufacturing
MOD
$10.3B
$29.7M 1.67%
111,261
+5,127
+5% +$1.35M
CRS icon
5
Carpenter Technology
CRS
$23.6B
$26.9M 1.52%
43,653
+1,897
+5% +$893K
LINC icon
6
Lincoln Educational Services
LINC
$813M
$26.5M 1.5%
531,935
+72,426
+16% +$3.28M
NVDA icon
7
NVIDIA
NVDA
$5.56T
$25.3M 1.43%
126,682
+8,335
+7% +$1.71M
STRL icon
8
Sterling Infrastructure
STRL
$14.9B
$25.3M 1.42%
30,120
-19,568
-39% -$13.7M
AXSM icon
9
Axsome Therapeutics
AXSM
$10.8B
$24.2M 1.36%
98,974
+17,496
+21% +$3.79M
GEV icon
10
GE Vernova
GEV
$251B
$24.1M 1.36%
20,532
-9,878
-32% -$10.1M
XENE icon
11
Xenon Pharmaceuticals
XENE
$5.79B
$23.9M 1.35%
395,844
+148,743
+60% +$8.26M
BBIO icon
12
BridgeBio Pharma
BBIO
$14.6B
$23.2M 1.31%
311,494
+12,585
+4% +$881K
LSCC icon
13
Lattice Semiconductor
LSCC
$16.5B
$22.4M 1.26%
146,318
+5,687
+4% +$734K
KTB icon
14
Kontoor Brands
KTB
$4.02B
$21.8M 1.23%
+261,117
New +$19M
TSM icon
15
TSMC
TSM
$2.22T
$21.5M 1.21%
44,929
+3,867
+9% +$1.57M
WTFC icon
16
Wintrust Financial
WTFC
$10.4B
$20.9M 1.18%
130,326
+13,485
+12% +$2.03M
SITM icon
17
SiTime
SITM
$18.4B
$20.5M 1.16%
27,562
+770
+3% +$486K
TFII icon
18
TFI International
TFII
$11.3B
$20.3M 1.14%
141,226
+7,606
+6% +$1.07M
MIRM icon
19
Mirum Pharmaceuticals
MIRM
$6.15B
$20.2M 1.14%
172,695
+41,392
+32% +$4.16M
ELVN icon
20
Enliven Therapeutics
ELVN
$4.35B
$19.9M 1.12%
391,529
+208,801
+114% +$8.86M
AVGO icon
21
Broadcom
AVGO
$1.7T
$19.8M 1.11%
52,405
SPHR icon
22
Sphere Entertainment
SPHR
$5.11B
$19.8M 1.11%
114,396
+5,646
+5% +$787K
DNTH icon
23
Dianthus Therapeutics
DNTH
$6.05B
$18.2M 1.03%
186,769
+135,519
+264% +$11.8M
AMZN icon
24
Amazon
AMZN
$2.79T
$17.9M 1.01%
75,046
+4,698
+7% +$1.18M
CYTK icon
25
Cytokinetics
CYTK
$10.1B
$17.8M 1%
209,071
+139,226
+199% +$10M

Similar funds

Nicholas Investment Partners's Q2 2026 Portfolio in Review

As of Q2 2026, Nicholas Investment Partners held 245 positions worth $1.78B, up 28% from $1.39B the previous quarter. Its ten largest holdings account for 18% of the portfolio.

Nicholas Investment Partners withdrew a net $130M in Q2 2026, closing 41 positions and reducing 41 holdings. Its most notable exit was Kratos Defense & Security Solutions, an estimated $27.6M position sold in full.

By sector, the portfolio is most concentrated in Technology at 21% of assets, up from 18% a quarter earlier, followed by Industrials and Healthcare.

Against the trend, Nicholas Investment Partners opened a new position in Kontoor Brands worth $21.8M.

  • Nicholas Investment Partners's largest Q2 2026 buy was Kontoor Brands: 261,117 shares worth $21.8M.
  • Nicholas Investment Partners added most to Callaway Golf Company in Q2 2026, an estimated $13M increase.
  • Nicholas Investment Partners's biggest Q2 2026 reduction was Bloom Energy, cutting an estimated $28.4M.
  • Nicholas Investment Partners fully exited Kratos Defense & Security Solutions in Q2 2026, selling an estimated $27.6M.
  • Nicholas Investment Partners's ten largest holdings make up 18% of its $1.78B portfolio in Q2 2026.
  • Nicholas Investment Partners opened 38 new positions and closed 41 in Q2 2026.
  • Nicholas Investment Partners's portfolio value rose 28% quarter-over-quarter to $1.78B.

Based on Nicholas Investment Partners's 13F filing for Q2 2026, filed 14 Aug 2026.